Modifiers of Disease Severity in Cerebral Cavernous Malformations

Active, not recruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

April 27, 2010

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Cavernous Angioma, FamilialCerebral Cavernous MalformationsCerebral Cavernous Hemangioma
Trial Locations (7)

22901

Alliance to Cure Cavernous Malformation, Charlottesville

45229

Cincinnati Children's Hospital, Division of Pediatric Neurosurgery, Cerebrovascular Program, Cincinnati

60637

University of Chicago, Medicine and Biological Sciences, Chicago

85013

Barrow Neurological Institute, Phoenix

87131

University of New Mexico Health Sciences Center, Albuquerque

94143

University of California, San Francisco, San Francisco

02115

Boston Children's Hospital, Boston

All Listed Sponsors
collaborator

University of New Mexico

OTHER

collaborator

University of Chicago

OTHER

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

Boston Children's Hospital

OTHER

collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

collaborator

Barrow Neurological Institute

OTHER

collaborator

Alliance to Cure Cavernous Malformation

UNKNOWN

lead

University of California, San Francisco

OTHER